|
BMY
|
Bristol-Myers Squibb Company
|
0.40%
|
US
|
NYSE
|
|
STAA
|
STAAR Surgical Company
|
0.39%
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
0.39%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
0.39%
|
US
|
NASDAQ
|
|
SN
|
Smith & Nephew
|
0.39%
|
UK
|
LSE
|
|
SEM
|
Select Medical Holdings Corporation
|
0.39%
|
US
|
NYSE
|
|
DOO
|
BRP Inc.
|
0.39%
|
CA
|
TSX
|
|
CGF
|
Challenger Ltd
|
0.39%
|
AU
|
ASX
|
|
EXEL
|
Exelixis, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
DSY
|
Discovery Holdings Ltd
|
0.38%
|
ZA
|
JSE
|
|
2888
|
Shin Kong Financial Holding Co Ltd
|
0.38%
|
TW
|
TW
|
|
POW
|
Power Corporation Of Canada
|
0.38%
|
CA
|
TSX
|
|
PTCT
|
PTC Therapeutics, Inc.
|
0.37%
|
US
|
NASDAQ
|
|
MNG
|
M&G Plc
|
0.37%
|
UK
|
LSE
|
|
SHL
|
Sonic Healthcare Limited
|
0.37%
|
AU
|
ASX
|
|
MPL
|
Medibank Private Ltd
|
0.37%
|
AU
|
ASX
|
|
NN
|
NN Group NV
|
0.37%
|
NL
|
AS
|
|
DVA
|
DaVita HealthCare Partners Inc.
|
0.36%
|
US
|
NYSE
|
|
LIVN
|
LivaNova PLC
|
0.35%
|
US
|
NASDAQ
|
|
RHC
|
Ramsay Health Care Limited
|
0.35%
|
AU
|
ASX
|